329.83
329.83 (0%)
As of Apr 01, 2024
Karuna Therapeutics Inc [KRTX]
Source:
Company Overview
Karuna Therapeutics, Inc is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions.
| Country | United States |
| Headquarters | boston, massachusetts |
| Phone Number | (857) 449-2244 |
| Industry | manufacturing |
| CEO | William Meury |
| Website | www.karunatx.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.7 |
| Operating Profit | $-494.8 |
| Net Income | $-433.7 |
| Net Cash | $-62.8 |
Profit Ratios
| Gross Margin | |
| Operating Margin | -75,654 |
| Profit as % of Revenues | |
| Profit as % of Assets | -34.7% |
| Profit as % of Stockholder Equity | -34.6% |
Management Effectiveness
| Return on Equity | -0.1% |
| Return on Assets | -0.1% |
| Turnover Ratio | 0% |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,336.2 |
| Total Liabilities | $82 |
| Operating Cash Flow | $-385.8 |
| Investing Cash Flow | $-160.3 |
| Financing Cash Flow | $483.4 |
